专论编号 | 物质名称 | 证书持有人 | 持有人ORG-ID和LOC-ID | 证书编号 | 发布日期 | 证书状态 | 到期续期 | 证书结束日期 | 证书类型 | 上一程序的结束日期 | 历史数据 程序类型|结论|日期 |
---|---|---|---|---|---|---|---|---|---|---|---|
2594 | Duloxetine hydrochloride | EGIS Pharmaceuticals PLC Budapest HU | 100001091;100001662 | CEP 2023-144 - Rev 00 | 2024/12/19 | Valid | 19/12/2029 | Chemical | 2024/12/20 | New application|CEP granted|20/12/2024 | |
2778 | Sitagliptin phosphate monohydrate, Process II | AMI LIFESCIENCES PRIVATE LIMITED Karakhadi IN | 100021822;100030527 | CEP 2024-249 - Rev 00 | 2024/12/19 | Valid | 19/12/2029 | Chemical | 2024/12/20 | New application|CEP granted|20/12/2024 | |
491 | Ethylmorphine Hydrochloride | ALCALIBER S.A.U. Madrid ES | 100020633;100087731 | CEP 2018-253 - Rev 02 | 2024/12/18 | Valid | Chemical | 2024/12/18 | Renewal|CEP granted|18/12/2024; Notification|CEP granted|23/01/2024 |
||
2787 | Esomeprazole magnesium dihydrate, Micronized, Non-micronized | QUIMICA SINTETICA S.A. Alcala De Henares ES | 100012121;100019020 | CEP 2023-283 - Rev 00 | 2024/12/18 | Valid | 18/12/2029 | Chemical | 2024/12/18 | New application|CEP granted|18/12/2024 | |
2219 | Lansoprazole | NOSCH LABS PRIVATE LIMITED Hyderabad IN | 100020550;100029297 | CEP 2010-309 - Rev 02 | 2024/12/18 | Valid | Chemical | 2024/12/18 | Minor revision|CEP granted|18/12/2024; Notification|CEP granted|06/08/2021 |
||
49 | Paracetamol, 14 micronised grades | Atabay Kimya Sanayi Ve Ticaret A.S. Istanbul TR | 100017338;100026137 | CEP 1995-050 - Rev 06 | 2024/12/18 | Valid | Chemical | 2024/12/18 | Minor revision|CEP granted|18/12/2024; Monograph revision|CEP granted|08/02/2023 |
||
2064 | Chondroitin sulfate sodium, Terrestrial origin, Process B | BIOIBERICA, S.A.U. Palafolls ES | 100000136;100043853 | CEP 2023-243 - Rev 02 | 2024/12/18 | Valid | 25/09/2028 | Chemical and TSE | 2024/12/18 | Minor revision|CEP granted|18/12/2024; Administrative procedure|CEP granted|25/10/2023; New application|CEP granted|25/09/2023 |
|
883 | Calcitriol, Process 2 (F007V1) | FORMOSA LABORATORIES, INC. Taoyuan TW | 100011879;100018688 | CEP 2020-150 - Rev 02 | 2024/12/18 | Valid | 22/10/2026 | Chemical | 2024/12/18 | Monograph revision|CEP granted|18/12/2024; Administrative procedure|CEP granted|18/11/2021; New application|CEP granted|22/10/2021 |
|
883 | Calcitriol | FORMOSA LABORATORIES, INC. Taoyuan TW | 100011879;100018688 | CEP 2009-377 - Rev 02 | 2024/12/18 | Valid | Chemical and TSE | 2024/12/18 | Monograph revision|CEP granted|18/12/2024 | ||
1442 | Leuprorelin | SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN | 100008538;100018201 | CEP 2014-278 - Rev 01 | 2024/12/18 | Valid | Chemical | 2024/12/19 | Minor revision|CEP granted|19/12/2024; Renewal|CEP granted|26/02/2021 |
||
2410 | 2,4-dichlorobenzyl alcohol | BIOXERA PHARMA PRIVATE LTD. Ambernath IN | 100023820;100032988 | CEP 2014-346 - Rev 01 | 2024/12/18 | Valid | Chemical | 2024/12/19 | Minor revision|CEP granted|19/12/2024; Renewal|CEP granted|28/01/2022 |
||
2791 | Clopidogrel hydrochloride | KRKA, d.d., Novo mesto Novo mesto SI | 100000627;100009540 | CEP 2018-251 - Rev 01 | 2024/12/18 | Valid | Chemical | 2024/12/19 | Renewal|CEP granted|19/12/2024; Minor revision|Accepted - CEP remains valid|25/03/2022 |
||
2583 | Montelukast sodium | HETERO DRUGS LIMITED Hyderabad IN | 100008415;100014434 | CEP 2012-318 - Rev 02 | 2024/12/18 | Valid | Chemical | 2024/12/19 | Monograph revision|CEP granted|19/12/2024; Minor revision|CEP granted|23/05/2023; Minor revision|Accepted - CEP remains valid|09/12/2021 |
||
1573 | Sumatriptan succinate, Micronised and Non-micronised | MSN PHARMACHEM PRIVATE LIMITED Sangareddy District IN | 100014794;100023345 | CEP 2009-096 - Rev 05 | 2024/12/18 | Valid | Chemical | 2024/12/19 | Minor revision|CEP granted|19/12/2024; Notification|CEP granted|25/10/2023; Minor revision|CEP granted|27/07/2022; Minor revision|CEP granted|11/03/2021 |
||
2933 | Deferasirox | ZHEJIANG HENGKANG PHARMACEUTICAL CO., LTD. Sanmen CN | 100034135;100082085 | CEP 2024-292 - Rev 00 | 2024/12/18 | Valid | 18/12/2029 | Chemical | 2024/12/19 | New application|CEP granted|19/12/2024 | |
2020 | Rilmenidine dihydrogen phosphate | ZENTIVA K.S. Prague CZ | 100004108;100002580 | CEP 2023-124 - Rev 00 | 2024/12/18 | Valid | 18/12/2029 | Chemical | 2024/12/19 | New application|CEP granted|19/12/2024 | |
603 | Disulfiram, Milled | ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdański PL | 100000470;100001572 | CEP 2022-090 - Rev 01 | 2024/12/18 | Valid | 13/08/2029 | Chemical | 2024/12/19 | Notification|CEP granted|19/12/2024; New application|CEP granted|13/08/2024 |
|
312 | Betamethasone | AURISCO PHARMACEUTICAL CO., LTD. Tiantai CN | 100011968;100018590 | CEP 2022-196 - Rev 01 | 2024/12/18 | Valid | 13/11/2029 | Chemical | 2024/12/19 | Minor revision|CEP granted|19/12/2024; New application|CEP granted|13/11/2024 |
|
1654 | Lymecycline | KOPRAN RESEARCH LABORATORIES LIMITED Mumbai IN | 100033667;100081898 | CEP 2020-040 - Rev 01 | 2024/12/18 | Valid | 18/09/2029 | Chemical | 2024/12/19 | Minor revision|CEP granted|19/12/2024; New application|CEP granted|18/09/2024 |
|
2531 | Clopidogrel hydrogen sulfate | SHANDONG LIXIN PHARMACEUTICAL CO. LTD. Zibo CN | 100048250;100079839 | CEP 2022-450 - Rev 00 | 2024/12/17 | Valid | 17/12/2029 | Chemical | 2024/12/17 | New application|CEP granted|17/12/2024 |